companydata.dkcompanydata.dk

LEKAPHARM A/S: Financial statements 2022

CVR: 32945945

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

LEKAPHARM A/S (CVR 32945945) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 2,968,088 and a net result of DKK 4,591 compared with DKK 458,999 the year before. That is a decrease of 29.6% compared with the year before. Equity in the 2022 report amounted to DKK 5,938,744. The solvency ratio was 52%. The company had 5 employees in the financial year.

Gross Profit
DKK 2,968,088
Profit/Loss
DKK 4,591
Equity
DKK 5,938,744
Total Assets
DKK 11,413,284
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-3 mio.5 t.5.9 mio.5
2021-4.2 mio.459 t.6.4 mio.5
2020-3.6 mio.404 t.9.9 mio.3
2019-3.3 mio.633 t.10 mio.3
2018-3.9 mio.1.1 mio.10.4 mio.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on LEKAPHARM A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

LEKAPHARM A/S: The 2021 annual report is outMay 25, 2022

LEKAPHARM A/S has published its annual report for 2021. Gross profit came to DKK 4,218,210, and the net result was DKK 458,999.

Emil Bødker Kjeldsen joins the board of LEKAPHARM A/SMay 20, 2022

As of May 20, 2022, Emil Bødker Kjeldsen has joined the board of directors of LEKAPHARM A/S.

Jacob Penney Kjeldsen leaves the board of LEKAPHARM A/SMay 20, 2022

As of May 20, 2022, Jacob Penney Kjeldsen has left the board of directors of LEKAPHARM A/S.

Claus Skærsholm Kjeldsen leaves the board of LEKAPHARM A/SMay 20, 2022

As of May 20, 2022, Claus Skærsholm Kjeldsen has left the board of directors of LEKAPHARM A/S.

About LEKAPHARM A/S

LEKAPHARM A/S is a Danish company of the type Aktieselskab based in Kværndrup, founded in 2010. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Lasse Kjeldsen. The board consists of Susanne Frederiksen (chair), Emil Bødker Kjeldsen and Lasse Kjeldsen. The company is owned by LKJ HOLDING 2010 ApS, CE-PHARMAMACHINERY ApS and Familien Kjeldsen Holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 10,369,416 and a net result of DKK 5,517,066 compared with DKK 2,051,529 the year before. Equity in the 2025 report amounted to DKK 7,972,163.

Source: annual report 2025, Danish Business Authority